NL7908988A - Paracetamolderivaat, de bereiding en toepassing daar- van. - Google Patents
Paracetamolderivaat, de bereiding en toepassing daar- van. Download PDFInfo
- Publication number
- NL7908988A NL7908988A NL7908988A NL7908988A NL7908988A NL 7908988 A NL7908988 A NL 7908988A NL 7908988 A NL7908988 A NL 7908988A NL 7908988 A NL7908988 A NL 7908988A NL 7908988 A NL7908988 A NL 7908988A
- Authority
- NL
- Netherlands
- Prior art keywords
- salt
- compound
- glycine
- preparation
- adenosine
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims description 8
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical class CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 title description 11
- 150000001875 compounds Chemical class 0.000 claims description 11
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims description 10
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 10
- 230000000202 analgesic effect Effects 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 230000001754 anti-pyretic effect Effects 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- 239000004471 Glycine Substances 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims description 4
- 150000003838 adenosines Chemical class 0.000 claims description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 3
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 claims description 2
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims description 2
- 229960005305 adenosine Drugs 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 2
- 238000001990 intravenous administration Methods 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims 2
- 125000003277 amino group Chemical group 0.000 claims 1
- 150000008064 anhydrides Chemical class 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 241000699670 Mus sp. Species 0.000 description 8
- 229960005489 paracetamol Drugs 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 4
- 230000007059 acute toxicity Effects 0.000 description 4
- 231100000403 acute toxicity Toxicity 0.000 description 4
- 150000002333 glycines Chemical class 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- PSQWZQGQIUGIRU-UHFFFAOYSA-N (4-acetamidophenyl) dihydrogen phosphate Chemical compound CC(=O)NC1=CC=C(OP(O)(O)=O)C=C1 PSQWZQGQIUGIRU-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 150000004682 monohydrates Chemical class 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 1
- 241000238814 Orthoptera Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 241000906446 Theraps Species 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- KAKKHKRHCKCAGH-UHFFFAOYSA-L disodium;(4-nitrophenyl) phosphate;hexahydrate Chemical compound O.O.O.O.O.O.[Na+].[Na+].[O-][N+](=O)C1=CC=C(OP([O-])([O-])=O)C=C1 KAKKHKRHCKCAGH-UHFFFAOYSA-L 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- -1 glycine Chemical class 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- ZYPZVOKVDNSKLP-UHFFFAOYSA-N tris(4-aminophenyl) phosphate Chemical compound C1=CC(N)=CC=C1OP(=O)(OC=1C=CC(N)=CC=1)OC1=CC=C(N)C=C1 ZYPZVOKVDNSKLP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/12—Esters of phosphoric acids with hydroxyaryl compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7835429A FR2444043A1 (fr) | 1978-12-15 | 1978-12-15 | Nouveau derive du paracetamol, son procede de preparation et son utilisation en therapeutique |
| FR7835429 | 1978-12-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL7908988A true NL7908988A (nl) | 1980-06-17 |
Family
ID=9216203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL7908988A NL7908988A (nl) | 1978-12-15 | 1979-12-13 | Paracetamolderivaat, de bereiding en toepassing daar- van. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4322410A (fr) |
| JP (1) | JPS5583792A (fr) |
| BE (1) | BE880615A (fr) |
| CA (1) | CA1131627A (fr) |
| CH (1) | CH642378A5 (fr) |
| DE (1) | DE2949669A1 (fr) |
| ES (1) | ES8101613A1 (fr) |
| FR (1) | FR2444043A1 (fr) |
| GB (1) | GB2037772B (fr) |
| IT (1) | IT1126572B (fr) |
| NL (1) | NL7908988A (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4591582A (en) * | 1984-04-17 | 1986-05-27 | Research Corporation | Organophosphorus compounds useful as anticonvulsant agents |
| IT1213182B (it) * | 1984-06-25 | 1989-12-14 | Simes | Derivati di composti a struttura catecolamminica. |
| US4710566A (en) * | 1984-12-27 | 1987-12-01 | Yale University | Purification of the messenger RNA cap-binding protein |
| GB2289535B (en) * | 1994-05-13 | 1998-08-05 | Cambridge Life Sciences | Paracetamol phosphate for immunoassays |
| US5661138A (en) * | 1996-10-03 | 1997-08-26 | Clarion Pharmaceutical, Inc. | (o-Acyl-p-N-acylamino-phenyl)-O-phosphoethanolamines |
| EP2291084A4 (fr) | 2008-05-20 | 2012-04-25 | Neurogesx Inc | Promédicaments carbonatés et leurs méthodes d'utilisation |
| JP5757864B2 (ja) | 2008-05-20 | 2015-08-05 | ニューロジェシックス, インコーポレイテッド | 水溶性アセトアミノフェン類似体 |
| US9024055B2 (en) | 2011-09-22 | 2015-05-05 | Acorda Therapeutics, Inc. | Acetaminophen conjugates, compositions and methods of use thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE254421C (fr) * | 1911-08-02 | |||
| US2023551A (en) * | 1933-06-28 | 1935-12-10 | Rosenzweig Salo | Guaiacol compounds and the production thereof |
| US3032555A (en) * | 1955-11-03 | 1962-05-01 | Boots Pure Drug Co Ltd | Dichloroacetanilide esters and the manufacture thereof |
| US3107262A (en) * | 1962-01-25 | 1963-10-15 | Leo K Rochen | Alkyl acid phosphate salts |
-
1978
- 1978-12-15 FR FR7835429A patent/FR2444043A1/fr active Granted
-
1979
- 1979-12-04 CH CH1073879A patent/CH642378A5/fr not_active IP Right Cessation
- 1979-12-04 US US06/100,005 patent/US4322410A/en not_active Expired - Lifetime
- 1979-12-07 CA CA341,429A patent/CA1131627A/fr not_active Expired
- 1979-12-07 IT IT28015/79A patent/IT1126572B/it active
- 1979-12-11 DE DE19792949669 patent/DE2949669A1/de not_active Withdrawn
- 1979-12-11 GB GB7942697A patent/GB2037772B/en not_active Expired
- 1979-12-13 NL NL7908988A patent/NL7908988A/nl not_active Application Discontinuation
- 1979-12-14 JP JP16343479A patent/JPS5583792A/ja active Pending
- 1979-12-14 ES ES486948A patent/ES8101613A1/es not_active Expired
- 1979-12-14 BE BE2/58269A patent/BE880615A/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CH642378A5 (fr) | 1984-04-13 |
| FR2444043A1 (fr) | 1980-07-11 |
| JPS5583792A (en) | 1980-06-24 |
| GB2037772A (en) | 1980-07-16 |
| CA1131627A (fr) | 1982-09-14 |
| US4322410A (en) | 1982-03-30 |
| FR2444043B1 (fr) | 1981-07-24 |
| IT7928015A0 (it) | 1979-12-07 |
| IT1126572B (it) | 1986-05-21 |
| DE2949669A1 (de) | 1980-07-03 |
| BE880615A (fr) | 1980-06-16 |
| GB2037772B (en) | 1983-05-11 |
| ES486948A0 (es) | 1980-12-16 |
| ES8101613A1 (es) | 1980-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1950376B (zh) | 莪术醇衍生物、含该衍生物的组合物及所述衍生物的制药用途 | |
| DE2504565A1 (de) | Neue derivate von 1h-imidazo(4,5-c) pyridin-7-carboxylsaeuren und -saeureestern | |
| HU197295B (en) | Process for production of new derivatives of n-/2'-aminphenil/-benzamid and medical preparatives containing those as active substance | |
| GB2057437A (en) | Salts of (+)-catechin their preparation and use and compositions and formulations containing them | |
| NL7908988A (nl) | Paracetamolderivaat, de bereiding en toepassing daar- van. | |
| HU193409B (en) | Process for producing 2-square bracket -n-cyclohexyl-4-bracket-oxo-1,2,3,5-tetrahydro-imidazo-square bracket-2,1-b-square bracket closed-quinazolin-7-yl-bracket closed-oxy-alkqne-carboxamidyl-square bracket closed-alkan-acides | |
| EP0096870A1 (fr) | Esters du métronidazole avec la N,N-diméthylglycine et ses sels d'addition d'acides | |
| DE2263100C2 (de) | 5,5-Dimethyl-8-(3-methyl-2-octyl)-10-[4-(piperidino)-butyryloxy]-2-(2-propinyl)-1,2,3,4-tetrahydro-5H-[1]-benzopyrano[3,4-d]pyridin, Verfahren zu dessen Herstellung und die Verbindung enthaltende Arzneimittel | |
| Blackwood et al. | The Synthesis of 6-Chloropyridoxine. The Hydride Reduction of Pyridinedicarboxylic Acids | |
| CH628014A5 (en) | Gamma-aryl-gamma-oxoisovaleric acids having antiphlogistic and antalgic properties | |
| JPS6041670B2 (ja) | 2,6−ジメチル−1,4−ジヒドロピリジン−3,5−ジカルボン酸エステルおよびその製造方法 | |
| GB2098989A (en) | Lysine salts | |
| AU2012212707B2 (en) | Homo- and hetero-polyamino-acid derivatives of fullerene C60, method for producing same, and pharmaceutical compositions based on said derivatives | |
| CA2478867A1 (fr) | Formulations de derives d'anthraquinone | |
| US4259332A (en) | Novel taurine derivatives | |
| DE2632200A1 (de) | Pyrrolidinoaethyl-amide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel | |
| DE69323998T2 (de) | Pharmazeutisch aktive flavilium verbindungen | |
| CN103772323A (zh) | Dpp-4抑制剂化合物 | |
| US3461211A (en) | Lipotropic compositions and their administration | |
| SU1547251A1 (ru) | 2-Окси-3,5-дийод-N-[2-(4-галогеннафтокси-1)-5-хлорфенил]-бензамиды, обладающие противомал рийной активностью | |
| US4018792A (en) | 5-Cyano-thiophen-2-aldehyde-isothiosemicarbazones and process for preparing them | |
| JPS6348877B2 (fr) | ||
| US4795758A (en) | 5-[2-(pyrrolidin-1-yl)ethoxy]-p-cymene derivatives, the process for the preparation of the said derivatives and drugs in which the said derivatives are present | |
| JPS63112563A (ja) | プロカテロールの安定化方法 | |
| PT86621B (pt) | Processo para a preparacao de sais derivados de rifamicina e de composicoes farmaceuticas que os contem |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A85 | Still pending on 85-01-01 | ||
| BV | The patent application has lapsed |